Plasticity of reward neurocircuitry and the 'dark side' of drug addiction

Nature Neuroscience

Volumn 8, Issue 11, 2005, Pages 1442-1444

  Koob, George F ^a   Le Moal, Michel ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; GLUCOCORTICOID; NEUROPEPTIDE Y; NEUROTRANSMITTER; PSYCHOSTIMULANT AGENT;

BRAIN FUNCTION; BRAIN REGION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE PREDISPOSITION; DOPAMINERGIC SYSTEM; DRUG ABUSE; DRUG DEPENDENCE; DRUG INTOXICATION; DRUG SELF ADMINISTRATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; NERVE CELL PLASTICITY; NEUROBIOLOGY; NEUROIMAGING; NONHUMAN; PRIORITY JOURNAL; REVIEW; SOCIAL PSYCHOLOGY; WITHDRAWAL SYNDROME;

ANIMALS; HUMANS; NERVE NET; NEURONAL PLASTICITY; REWARD; SUBSTANCE-RELATED DISORDERS;

EID: 27644548739     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/nn1105-1442     Document Type: Review

References (22)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 4th edn. (American Psychiatric Press, Washington, D.C., 1994).
2. Koob, G.F. & Le Moal, M. Science 278, 52-58 (1997).
3. Martin, W.R. in The Addictive States (ed. Wikler, A.) 206-225 (Williams and Wilkins, Baltimore, 1968).
4. Shippenberg, T.S. & Koob, G.F. in Neuropsychopharmacology: The Fifth Generation of Progress (eds. Davis, K.L., Charney, D., Coyle, J.T. & Nemeroff, C.) 1381-1397 (Lippincott Williams and Wilkins, Philadelphia, 2002).
5. Koob, G.F. & Le Moal, M. Neuropsychopharmacology 24, 97-129 (2001).
6. Ahmed, S.H., Kenny, P.J., Koob, G.F. & Markou, A. Nat. Neurosci. 5, 625-626 (2002).
7. Volkow, N.D., Fowler, J.S. & Wang, G.J. J. Clin. Invest. 111, 1444-1451 (2003).
8. Koob, G.F. Alcohol. Clin. Exp. Res. 27, 232-243 (2003).
9. Koob, G.F. & Bloom, F.E. Science 242, 715-723 (1988).
10. Nestler, E.J. Nat. Rev. Neurosci. 2, 119-128 (2001).
11. Aston-Jones, G., Delfs, J.M., Druhan, J. & Zhu, Y. Ann. NY Acad. Sci. 877, 486-498 (1999).
12. Piazza, P.V. & Le Moal, M. Annu. Rev. Pharmacol. Toxicol. 36, 359-378 (1996).
13. Shaham, Y., Erb, S. & Stewart, J. Brain Res. Brain Res. Rev. 33, 13-33 (2000).
14. See, R.E., Fuchs, R.A., Ledford, C.C. & McLaughlin, J. Ann. NY Acad. Sci. 985, 294-307 (2003).
15. Le Moal, M. in Psychopharmacology: The Fourth Generation of Progress (eds. Bloom, F.E. & Kupfer, D.J.) 283-294 (Raven, New York, 1995).
16. Rasmussen, D.D. et al. Alcohol. Clin. Exp. Res. 24, 1836-1849 (2000).
17. Valdez, G.R. et al. Alcohol. Clin. Exp. Res. 26, 1494-1501 (2002).
18. Kreek, M.J. & Koob, G.F. Drug Alcohol Depend. 51, 23-47 (1998).
19. Deroche-Gamonet, V., Belin, D. & Piazza, P.V. Science 305, 1014-1017 (2004).
20. Vanderschuren, L.J. & Everitt, B.J. Science 305, 1017-1019 (2004).
21. World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 10th revision (World Health Organization, Geneva, 1992).
22. Solomon, R.L. & Corbit, J.D. Psychol. Rev. 81, 119-145 (1974).